in co-infected patients who did not receive HBV antiviral therapy in addition to HCV treatment.
for this indication; isoprinosine, an immunomodulatory drug used primarily as an antiviral agent, is not available in the U.S.) Improvements in fatigue, function, and work impairment as well as global
by careful study; therefore, antiviral therapy, including acyclovir, has no role in the treatment of CFS.
infection, and development of antiviral agents with improved efficacy.
However, in 2011, the FDA approved two new anti-HCV medications that demonstrated improved efficacy when used in combination with older antiviral therapies for patients with genotype 1, and other treatments
of a combination antiviral treatment regimen.
result in reduced antiviral activity of remdesivir and revoked the emergency use authorization that allowed for chloroquine phosphate and hydroxychloroquine sulfate to be used to treat hospitalized patients with COVID-19
Amantadine also has antiviral and antiparkinsonian properties. Although iron deficiency anemia should be part of the differential diagnosis when a patient with MS has fatigue, this patient does not show any
This patient's hepatitis B serologies indicate immunity to hepatitis B virus; therefore, an antiviral medication such as entecavir is not appropriate.
Maribavir (Livtencity) as the first drug to treat certain patients with post-transplant cytomegalovirus (CMV) infection that does not respond to available antiviral treatment. ... It may also reduce the antiviral activity of ganciclovir and valganciclovir